[Current antimicrobial agent series II: Ticarcillin].
D001419:Bacteria / Q000187:drug effects; D002969:Clavulanic Acids / Q000494:pharmacology; D004341:Drug Evaluation; D004359:Drug Therapy, Combination / Q000494:pharmacology; D006801:Humans; D010403:Penicillin Resistance; D010406:Penicillins / Q000494:pharmacology*; D012141:Respiratory Tract Infections / Q000188:drug therapy; D013982:Ticarcillin / Q000493:pharmacokinetics / Q000494:pharmacology* / Q000627:therapeutic use; D014552:Urinary Tract Infections / Q000188:drug therapy
D002969:Clavulanic Acids; D010406:Penicillins; C043215:ticarcillin-clavulanic acid; D013982:Ticarcillin